May 17, 2020

Sanofi wins Lipitor licence from Pfizer

Pfizer
Lipitor
Sanofi
drug
Admin
2 min
Pfizer will lose exclusive rights to Lipitor in 2012
Zentiva, the generic drug making arm of global pharmaceutical company Sanofi, has won a licence allowing it to produce Pfizers hugely popular cholester...

Zentiva, the generic drug making arm of global pharmaceutical company Sanofi, has won a licence allowing it to produce Pfizer’s hugely popular cholesterol-lowering drug Lipitor.

Pfizer is set to lose the exclusive patent rights to Lipitor on 7 May 2012, enabling generic drug companies to reproduce its active ingredient atorvastatine after that date.

However, French newspaper Les Echos is today reporting generic versions could be made available in France before Pfizer’s patent expires.

Pfizer has already lost exclusive rights to the drug in Spain, Brazil, Canada and Mexico.

To read the latest edition of Healthcare Global, click here

The deal has been agreed as part of the Strategic Council of Health Industries (CSIS) programme in France, where Lipitor is known under the brand name of Tahor.

This sees drugmakers receive a tax break for allowing cheaper, generic copies of its branded drugs to be made once it has lost the patents.

France’s CSIS programme is geared towards retaining production sites and employment in the country.

Sanofi is making a conscious effort to make generic drugs one of its main focuses, as it too is set to lose exclusive rights to some of its own pharmaceuticals.

This move by Pfizer comes just after the company settled a lawsuit with Indian pharmaceutical company Dr Reddy’s, which in 2009 tried to create a generic version of Lipitor.

Our magazine is now available on the iPad. Click here to download it.

Share article

Jun 17, 2021

Dexcom: changing the lives of people with type 1 diabetes

diabetes
glucosemonitoring
type1diabetes
insulin
3 min
British actress Nina Wadia OBE tells us how her son's life has changed since using glucose monitoring system Dexcom

It is estimated that 9.3% of adults around the world are living with type 1 diabetes, which amounts to a total of 463 million people. A further 1.1 million children and adolescents under the age of 20 are living with the condition. 

Unlike the more prevalent type 2 diabetes, where the body still produces insulin and symptoms develop slowly, people with type 1 diabetes need regular insulin injections or pumps, and must monitor their sugar levels frequently. 

In recent years a number of remote glucose monitoring systems have become available that patients can use at home. These work with a sensor, usually placed under the skin, that measures glucose levels every few minutes. This information is then transmitted wirelessly to a device like a smartphone or tablet, which can then be shared with their clinician. 

British actress Nina Wadia's son Aidan, 14, has type 1 diabetes, and has been managing his condition using Dexcom, a glucose monitoring system used by patients all over the world. Here Wadia explains how Dexcom has improved their lives. 

As a parent of someone with type 1 diabetes, what is your day-to-day life like?
Being able to take a breath, think and pivot constantly without getting frustrated becomes an essential mindset because sometimes it feels like each day is determined to be different from the day before. Whatever worked yesterday is going to misfire today. 

Which areas of yours and Aidan’s life are most impacted by diabetes? 
The one thing that you have to fight hard to reclaim is spontaneity, especially when it comes to food and exercise. It’s only when this is taken do you realise how essential each one is. You can be flexible and there are no real limits, but only in the sense that a great athlete can be flexible without limits because they’ve trained super hard to be that way. So we’ve all had to become athletes when it comes to being spontaneous.

How has Dexcom helped you and Aidan? 
Dexcom has brought future science fiction to real life today. The continuous glucose monitoring system is tiny, sits discreetly on his body and gives him a ten-day breather between sensor changes, so it's goodbye finger-pricking seven times daily. 

Dexcom is totally active at a grass roots level and for Diabetes Awareness has pledged to donate £2,000 if #DexcomDiabetesStories and/or #DexcomWarriorStories is shared 200 times! I’ll be sharing more on social media and would love to hear how other families are winning their fights.

Maybe most importantly Dexcom is trying to introduce a reimbursement programme for type 1 diabetes  patients which will give greater access to modern, life changing hi-tech. I want to spread the word on the importance of accessing it through this campaign. 

If you compared your life today with how it was before Aidan was using Dexcom, what has changed? 
It's always working, which lets him take his mind off diabetes for longer stretches. It also lets me get off his back. We both receive alerts so I no longer have to pester him by asking him what his number is, and especially importantly, I don’t have to wake him at night to prick his finger if I’m worried. Dexcom gave us back our sleep!

Share article